Skip to main content

Pneumococcal disease

Key facts

  • Pneumococcal disease can cause inflammation around the brain (meningitis), infection in the lungs (pneumonia), ear infections that can damage hearing and other serious diseases.

  • Some adolescents have certain health or medical conditions that put them at risk for pneumococcal disease. These adolescents are recommended to get additional vaccine doses to protect them against pneumococcal disease. These adolescents are recommended to receive one dose of a pneumococcal vaccine (20vPCV) to protect them against pneumococcal disease.

Last updated on 5 September 2025.

Share this page

What is pneumococcal disease?

Pneumococcal disease refers to a range of illnesses that affect different parts of the body and are caused by pneumococcal germs (bacteria). Pneumococcal infection can cause swelling around the brain (meningitis), infection in the lungs (pneumonia), ear infections that can damage hearing and other serious diseases.1

The infection spreads between people through droplets of saliva or mucous, such as from coughing, sneezing or kissing.

People with certain medical conditions, such as weak immune systems (immunocompromised) or those whose immune systems don’t work very well, are more likely to get very sick from pneumococcal disease.1

What will happen to my adolescent if they catch pneumococcal disease?

Usual symptoms

  • Symptoms of pneumococcal infection are different depending on what part of the body is affected. Many people will have fever or chills and feel unwell.
  • Middle ear infections are a common type of pneumococcal infection. Between 28 and 55% of middle ear infections (acute otitis media) are caused by pneumococcal disease.2
  • Lung infections (pneumonia) are also commonly caused by pneumococcal bacteria.2,3
  • Between 33 and 50% of people who are treated for lung infections (like pneumonia) in hospital have pneumococcal disease.3
     

Less common symptoms

  • Pneumococcal bacteria can cause infection of the brain lining (meningitis).2
  • They can also cause bloodstream infection (bacteraemia).2

If your adolescent is tested and diagnosed with pneumococcal disease, your local state or territory Public Health Unit (PHU) will be notified. The PHU can provide advice on any public health measures your household should follow. This may include staying home from school or work or wearing a mask.

What vaccine will protect my adolescent against pneumococcal disease?

Adolescents aged under 18 years with certain health or medical conditions are recommended to receive one dose of a pneumococcal vaccine (20vPCV) at diagnosis, or as soon as practical following diagnosis. 

In Australia, adolescents whose health or medical condition puts them at high risk for pneumococcal disease can receive a dose of the 20vPCV pneumococcal vaccine. This dose will help strengthen their immunity to various strains of the bacteria that cause pneumococcal disease.

This includes adolescents with:

  • a new health or medical risk condition
  • an existing health or medical risk condition who have not previously had all their recommended pneumococcal vaccines.

Speak with your doctor, nurse or community health worker to see when your adolescent is recommended to have these additional pneumococcal vaccines.

Read more about the number and type of pneumococcal vaccines your medically at-risk adolescent can receive

When should my adolescent be vaccinated?

It is recommended that anyone with a newly identified medical or health risk condition that puts them at a higher risk for pneumococcal disease receive additional doses of the pneumococcal vaccine. Health conditions that can increase the chance of pneumococcal disease include lung and heart diseases and having a weakened immune system.

If your adolescent was diagnosed with a certain medical or health risk condition as a baby or young child, they may have already received a vaccine to protect them from pneumococcal disease.

So, your adolescent’s vaccine schedule will depend on:

  • how old they are
  • when they were first diagnosed with a certain health or medical risk condition putting them at risk for pneumococcal disease
  • if they have had a pneumococcal vaccine before
  • Aboriginal and Torres Strait Islander status
  • the state or territory they live in.

Speak with your doctor, nurse or community health worker to understand what pneumococcal vaccine and schedule is recommended for your adolescent.

How do pneumococcal vaccines work?

Pneumococcal vaccines work by ‘training’ your adolescent’s immune system to recognise and get rid of pneumococcal bacteria. The vaccine contains antigens, which are tiny, harmless fragments of the outer layer of pneumococcal bacteria (the bacterial capsule). 

When your adolescent’s immune system detects the antigens in the vaccine, it produces antibodies. These antibodies are like soldiers that recognise and remember the pneumococcal bacterial outer layer. If your adolescent is ever exposed to the real pneumococcal bacteria, their immune system will recognise it quickly and fight it off using the antibodies it created after vaccination.4

The pneumococcal vaccine does not contain any blood products and is not a ‘live’ vaccine. The antigens are made synthetically. They cannot reproduce themselves or cause disease.

How effective are pneumococcal vaccines?

Pneumococcal disease is more common in people with certain medical risk conditions.5 So it is important that adolescents with these conditions follow their recommended pneumococcal vaccine schedule.

Will my adolescent catch pneumococcal disease from the vaccine?

No, there is no risk that your adolescent will catch pneumococcal disease from the vaccine, because the vaccine does not contain the live bacteria that cause the disease.

What are the common reactions to the vaccine?
  • About 60% of children with risk conditions for pneumococcal disease who get a pneumococcal vaccine (20vPCV) experience mild discomfort or pain where the injection was given. This can last one or two days after receiving the vaccine.1
  • About 61% of children who get a pneumococcal vaccine (20vPCV) are drowsy or tired for a day or two afterwards.6
  • About 39% of children who get a pneumococcal vaccine (20vPCV) have a reduced appetite after getting the vaccine.6
  • About 24% of children who get a pneumococcal vaccine (20vPCV) experience a high temperature (fever).6
Are there any rare and/or serious side effects to the vaccine?

To date, no rare or serious side effects to the pneumococcal vaccine have been found.

If your adolescent doesn’t seem to be getting better or you are worried about them, you can get help:

  • from your doctor
  • at your nearest emergency department
  • by calling Healthdirect on 1800 022 222.
What impact has vaccination had on the spread of pneumococcal disease?

Several different strains of pneumococcal bacteria can cause pneumococcal disease. Since pneumococcal vaccines were funded under the National Immunisation Program in 2005, disease rates for the strains covered by the pneumococcal vaccines has decreased greatly.7,8,9

Graph: Prevalence of pneumococcal disease

Sources: (i) Chiu C, Dey A, Wang H et al. Vaccine preventable diseases in Australia, 2005 to 2007. Communicable Diseases Intelligence 2010; 34;supplement December: S1-167; (ii) Updated with data from NNDSS Annual Report Writing Group. Australia’s notifiable disease status, 2010: annual report of the National Notifiable Diseases Surveillance System. Communicable Diseases Intelligence 2012;36:1-69

What if I still have questions?

You can read some answers to common questions here.

If you still have some questions about vaccinations for your adolescent, write them down and make an appointment with your nurse, your doctor or your health worker so you can ask them.

Please note: In SKAI Adolescent, the phrase ‘your adolescent’ refers to all guardian relationships where health decisions for an adolescent fall under your responsibility.

Drafts of this page were reviewed by members of our Consumer Advisory Group.


  1. Australian Technical Advisory Group on Immunisation. Pneumococcal disease. Australian Immunisation Handbook. Australian Government Department of Health and Aged Care; Canberra: 2025. Available from https://immunisationhandbook.health.gov.au/contents/vaccine-preventable-diseases/pneumococcal-disease
  2. Centers for Disease Control and Prevention. Pneumococcal disease. In Hamborsky J, Kroger A, Wolfe C (Eds). Epidemiology and prevention of vaccine-preventable diseases. 13th ed. Washington, DC: Public Health Foundation; 2015. Available from https://www.cdc.gov/pinkbook/hcp/table-of-contents/
  3. Charles PG, Whitby M, Fuller AJ, et al. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clinical Infectious Diseases 2008;46:1513-21
  4. Australian Academy of Science. The science of immunisation: questions and answers. 2021. Available from https://www.science.org.au/education/immunisation-climate-change-genetic-modification/science-immunisation
  5. Mitchell R, Trück J, Pollard AJ. Use of the 13-valent pneumococcal conjugate vaccine in children and adolescents aged 6-17 years. Expert Opinion on Biological Therapy 2013;13:1451-65
  6. Korbal P, Wysocki J, Jackowska T, et al. Phase 3 safety and immunogenicity study of a three-dose series of twenty-valent pneumococcal conjugate vaccine in healthy infants and toddlers. The Pediatric infectious disease journal. 2024;43(6):587-95
  7. NNDSS Annual Report Working Group. Australia’s notifiable disease status, 2016: annual report of the National Notifiable Diseases Surveillance System. Communicable Diseases Intelligence (2018) 2021;45
  8. Chiu C, Dey A, Wang H et al. Vaccine preventable diseases in Australia, 2005 to 2007. Communicable Diseases Intelligence 2010;34;supplement;December: S1-167
  9. Updated with data from NNDSS Annual Report Writing Group. Australia’s notifiable disease status, 2010: annual report of the National Notifiable Diseases Surveillance System. Communicable Diseases Intelligence 2012;36:1-69